EUVIMEDEUVIMED entdecken
Crossref

Oleandrin Suppresses the PI3K/AKT Pathway to Inhibit Growth and Induce Apoptosis in T-cell Acute Lymphoblastic Leukemia Cells and Xenograft Mice

Haihui Zhuang, Xia Jiang, Fenglin Li, Wenjie Sha, Ying Lu iD

Planta Medica · 01.08.2026 · 92 (09) · 891-900

DOI: 10.1055/a-2816-0955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.08.2026. Verfasst von Haihui Zhuang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Apoptosis, Proto-Oncogene Proteins c-akt, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Cardenolides. Gefördert von: Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project, Natural Science Foundation of Zhejiang, Science and Technology Project of Agriculture and Social Science of Ningbo Yinzhou District.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractT-cell acute lymphoblastic leukemia (T-ALL) remains a clinical challenge due to its high relapse rate and limited treatment options. This study aimed to investigate the cytotoxic effects of oleandrin on T-ALL and its underlying mechanism to explore novel therapeutic strategies. In human T-ALL cell lines, it inhibited cell growth and induced apoptosis in a dose- and time-dependent manner, with half-maximal inhibitory concentration (IC₅₀) values ranging from 16 to 31 nM. In mouse xenograft models, oleandrin reduced tumor burden and prolonged survival without significant toxicity. Integrated mechanistic studies, including network pharmacology, transcriptomics, and Western blot analysis, indicated that the anti-leukemic effects of oleandrin are associated with suppression of the PI3K/AKT signaling pathway, as evidenced by reduced levels of key proteins such as PIK3CA, phosphorylated AKT (p-AKT), phosphorylated GSK3β (p-GSK3β), c-Myc, Bcl-2, and Bcl-xL. These findings suggest oleandrin is a promising therapeutic candidate for T-ALL, likely through suppression of the PI3K/AKT pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisProto-Oncogene Proteins c-aktPrecursor T-Cell Lymphoblastic Leukemia-LymphomaCardenolidesAntineoplastic Agents, PhytogenicAnimalsHumansSignal TransductionMicePhosphatidylinositol 3-KinasesCell Line, TumorXenograft Model Antitumor AssaysCell Proliferation

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesoleandrinCardenolidesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.
  • Institute of Hematology, Ningbo University, Ningbo, China.

ORCID-Profile: Ying Lu

Förderung

  • Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project
  • Natural Science Foundation of Zhejiang
  • Science and Technology Project of Agriculture and Social Science of Ningbo Yinzhou District

Zitieren

APA

Zhuang, H., Jiang, X., Li, F., Sha, W., & Lu, Y. (2026). Oleandrin Suppresses the PI3K/AKT Pathway to Inhibit Growth and Induce Apoptosis in T-cell Acute Lymphoblastic Leukemia Cells and Xenograft Mice. Planta Medica, 92(09), 891-900. https://doi.org/10.1055/a-2816-0955

Vancouver

Zhuang H, Jiang X, Li F, Sha W, Lu Y. Oleandrin Suppresses the PI3K/AKT Pathway to Inhibit Growth and Induce Apoptosis in T-cell Acute Lymphoblastic Leukemia Cells and Xenograft Mice. Planta Medica. 2026;92(09):891-900. doi:10.1055/a-2816-0955

BibTeX
@article{Zhuang2026,
  author = {Zhuang, Haihui and Jiang, Xia and Li, Fenglin and Sha, Wenjie and Lu, Ying},
  title = {Oleandrin Suppresses the PI3K/AKT Pathway to Inhibit Growth and Induce Apoptosis in T-cell Acute Lymphoblastic Leukemia Cells and Xenograft Mice},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {09},
  pages = {891--900},
  doi = {10.1055/a-2816-0955}
}
Kostenlos starten →